The Center for Disease Control has awarded researchers at Dana-Farber Cancer Institute two grants totaling $3 million to develop workplace-based health promotion and prevention programs.
It will be snowing art in November and December when original works"” decorated snowflakes"” by some of the best-known award-winning children's book illustrators will be auctioned online in a charity event, Robert's Snow: for Cancer's Cure.
Young women who were treated for cancer as children have a greater chance of developing breast cancer if their treatment included chest radiation, if they initially had cancer of the bones, muscles, or connective tissue, or had a family history of breast cancer, according to a new study.
Scientists at Dana-Farber Cancer Institute have corrected a flaw in cancer cells that lets them evade the normal cell-death process, and as a result they eliminated leukemia cells from mice.
The Lance Armstrong Foundation has given a $1 million gift to Dana-Farber Cancer Institute to establish the Lance Armstrong Foundation Adult Survivorship Clinic. The clinic, which will be part of the Perini Family Survivors' Center, will expand Dana-Farber's commitment to serving cancer survivors of all ages.
Dana-Farber Cancer Institute researchers have found that removing three key proteins believed essential to cell division and growth had little impact on normal tissue development of a mouse embryo.
Researchers have found that adding only six months of hormone therapy to external beam radiation therapy for localized prostate cancer increased patients' likelihood of surviving to five years by 10 percent.
In the first comprehensive survey of gene activity in each cell type composing normal and malignant breast tissue, scientists at Dana-Farber Cancer Institute have identified genes in non-cancerous supporting cells that can spur the growth of breast cancer cells.
A potent chemotherapy that is highly effective in treating the most common form of childhood leukemia can significantly harm the heart, but findings from a multi-center study suggest that adding an experimental drug to the therapy can reduce or prevent the damage.
Research into the many-sided interactions of proteins in yeast cells is revealing that such networks may have something in common with other kinds of systems, from the World Wide Web to the country's electric-power grid.
Scientists at Dana-Farber Cancer Institute have uncovered new evidence that Waldenstrom's macroglobulinemia can run in families. Investigators will document these findings, as well as their discovery that certain markings on the surface of Waldenstrom's tumor cells may indicate a subtype of the disease.
A new pill that targets several molecules implicated in the growth of cancer has shown promise in combating gastrointestinal tumors that no longer respond to the targeted drug Gleevec.
Do African Americans with early-stage non-small cell lung cancer (NSCLC) have a lower overall survival rate than Caucasians with the disease because they have less access to adequate medical care, or because they are less likely to agree to lung surgery when offered? A study offers evidence that both factors may play a role.
Early results from a major, international Phase III clinical trial decisively show that recurrent multiple myeloma is more effectively treated with the drug bortezomib (trade name: Velcade TM) than with dexamethasone, a drug that for decades has been the standard therapy for relapsed disease.
The establishment of the Center for Applied Cancer Science, a far-reaching initiative designed to convert basic molecular discoveries into new therapies for cancer, is announced.
Researchers have pinpointed a crucial gene on which the normal development of the body's entire blood system depends. If the gene is absent, even the most basic blood stem cells cannot be generated. In a mutated form, this gene can cause a rare and devastating form of leukemia.
A study suggests that a person's occupation is a distinct and significant factor - in addition to education, income, race/ethnicity, and gender - in determining which groups of adults bear the greatest burden of smoking, and which may especially benefit from smoking-cessation efforts.
An antibody plucked from a "library" of human antibodies has powerfully blocked infection by the SARS virus in laboratory tests. This discovery could expedite the development of an antibody drug for the prevention or early treatment of SARS.
Some oncologists contend that patients in cancer trials experience better outcomes than non-participants - a benefit known as a "trial effect." Researchers reviewed 26 published cancer studies and found little convincing evidence that a trial effect exists.
Researchers have created bioengineered mice that develop aggressive, fatal pancreatic cancer through the same genetic mishaps that cause the disease in humans.
A survey of young breast cancer survivors found that more than half likely overestimated their risk for developing treatment related infertility, according to researchers. The study is the largest to date that addresses fertility and menopausal concerns among young women with breast cancer.
Women who chose not to receive radiation therapy following surgery for Ductal Carcinoma In Situ experienced recurrences at a surprisingly high rate. This suggests that surgery alone is inadequate in treating these small, very early breast cancers.
Scientists have discovered an enzyme they say accounts for a cancer-causing protein's Jekyll-and-Hyde personality. Normally, the protein regulates when and how body parts develop, but when mutated, it triggers a rare, often-lethal infant leukemia called mixed lineage leukemia.
In a step toward a practical vaccine for advanced melanoma, a notoriously difficult-to-treat form of cancer, researchers have demonstrated the effectiveness of a vaccine that is safer and easier to produce than earlier versions.
In the process of figuring out why an anti-cancer drug is effective in treating patients with the rare blood disorder hypereosinophilic syndrome, researchers at Brigham and Women's Hospital and Dana-Farber Cancer Institute have shown that it is a form of cancer.
Barriers to healthy lifestyles, early detection services and good medical care contribute to higher cancer incidence and mortality rates for African Americans and other medically underserved minorities in this country, when compared with white U.S. citizens.
The Dana-Farber Cancer Institute and the National Foundation for Cancer Research announced today the establishment of the NFCR Center for Therapeutic Antibody Engineering at Dana-Farber to assist scientists in developing new antibodies for cancer research.
March is national colorectal cancer awareness month, and Dana-Farber Cancer Institute physicians and nurses are encouraging people who are age 50 and older to be screened regularly for the disease.
A relatively brief screening test can give caregivers a good indication of which cancer survivors are emotionally distressed and may benefit from further psychological evaluation, according to new research by a team of Dana-Farber Cancer Institute investigators.
A multi-institutional study has shown that adding two experimental drugs to the standard four-drug chemotherapy regimen significantly improved survival in patients with non-metastatic Ewing's sarcoma, a highly malignant bone cancer of children and young adults.
In a demonstration of a vaccine therapy's potential for treating lung cancer, Dana-Farber Cancer Institute scientists report that a prototype vaccine boosted the natural immune response to tumors in a small group of patients with advanced non-small cell lung cancer.
Dana-Farber researchers have made a discovery that could help explain how a child's sunburn can develop into a deadly tumor decades later. The findings may lead to a means of distinguishing, at an early stage, cancerous moles from non-cancerous ones.
A study led by researchers at Dana-Farber Cancer Institute has shown that a drug extracted from porcine intestinal tissue reduced the risk of death in patients who experienced severe veno-occlusive disease, an often-fatal complication of stem cell transplants.
Research has shown that a diet high in starchy foods may increase the risk of pancreatic cancer in women who are overweight and sedentary. The study suggests that excess insulin can promote the development of pancreatic cancer.
Blue-collar workers are more likely to quit smoking when workplace smoking cessation programs are combined with other occupational health and safety messages rather than when singled out, according to a study headed by Dana-Farber Cancer Institute researchers. The findings may lead to a new approach to improving working-class people's health.
An international study questions the value of chemotherapy following breast surgery in postmenopausal women with lymph node-negative tumors that are responsive to estrogen. However, patients whose tumors were unresponsive to estrogen did benefit from chemotherapy.
A decade of research into one of the world's least-known diseases has resulted in a major advance against one of the best-known: the discovery of six genes linked to inherited breast cancer. Dana-Farber Cancer Institute researchers and colleagues report that an error in any of six Fanconi anemia genes can increase a person's risk of developing breast cancer.
Many young women treated with chest radiation for Hodgkin's disease are not aware that they have an increased risk of developing breast cancer later in life. Moreover, among those who are aware of their increased risk, many fail to have regular mammograms, according to a new study led by researchers at Dana-Farber Cancer Institute.
Dana-Farber researchers have identified the underlying mechanism that causes one of tamoxifen's side effects. The findings may lead to new medications that reduce the risk of certain types of breast cancer, but don't carry tamoxifen's potential downside.
People who have a parent or sibling with colon cancer can markedly reduce their own chances of developing the disease by taking a daily multivitamin that includes folic acid and limiting their intake of alcohol, per a Dana-Farber, Brigham and Women's, and HSPH study.
1) Social influences in the workplace contribute to occupational differences in quitting smoking; 2) Childhood cancer patients find survival is the first step in lifelong battle.
Dana-Farber researchers have developed a powerful method for detecting foreign bacteria and viruses in human tissue samples, even if the organisms haven't previously been encountered. The microbe-hunting method relies on DNA sequence data.
1) Study upends earlier thinking about immune cells' readiness against disease; 2) Drawing a new map of cancer: gene chips help sort out cancer types; 3) Researchers to examine disparity in cancer care among minorities.
Dana-Farber Cancer Institute scientists have discovered that a rare but lethal blood cancer that strikes infants in their first year is a genetically distinct type of leukemia that might someday be treatable with designer drugs specifically targeted to it.
While most cancer patients enrolled in clinical trials understand the primary purpose of the research, nearly one quarter of the participants do not realize that clinical trials are conducted mainly to benefit future patients, not themselves.
Using miniaturized chips that make snapshots of the activity of thousands of genes at once, Dana-Farber Cancer Institute scientists have divided lung cancers into new categories based on their gene functions rather than the cells' appearance under a microscope.
By manipulating a cell that controls the immune system's response to infections, researchers at Dana-Farber Cancer Institute and their colleague have prevented the onset of diabetes in mice predisposed to the disease. The finding one day may lead to the development of a preventive therapy for people at risk for type 1 diabetes.
Dana-Farber Cancer Institute researchers have discovered the long-sought molecular "switch" that regulates the liver's production of glucose, the sugar that fuels the brain but which builds up dangerously in the bloodstream of diabetics because this switch doesn't turn off. Researchers say it may be possible to design new drug treatments for diabetes as a result of the work.
New, three-dimensional images from researchers at Dana-Farber Cancer Institute provide the fullest picture yet of how the AIDS virus blunts the immune system's ability to mount an attack against infections and cancer.
Dana-Farber Cancer Institute and the University of Massachusetts Lowell announced a new national partnership between labor unions and tobacco control groups to reduce tobacco use and exposure to secondhand smoke among working families.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right